Abiomed celebrates $40 million expansion to Massachusetts headquarters

During a ceremony on March 30, Massachusetts Governor Charlie Baker and others celebrated the grand opening of Abiomed’s expanded headquarters in Danvers, Massachusetts.

Abiomed’s headquarters expanded from 60,000 square feet to 160,000 square feet. The company added new research and manufacturing capabilities and a new Heart Recovery Institute for clinical education, according to a company news release.

Since Abiomed broke ground on the project in June 2015, the company said it has added more than 150 engineering and manufacturing jobs at the site. The company also plans on expanding in Berlin and Aachen, Germany and Tokyo, Japan.

Abiomed manufactures the FDA-approved Impella 2.5, 5.0, CP and RP heart pumps. In February, the company announced that the 50,000th U.S. patients had been treated with an Impella heart pump.

Abiomed, which has been in Massachusetts since 1981, also honored two cardiac patients at the March 30 event who have benefited from the company’s technology. Abiomed named conference rooms after patients Rogelio Landin of Detroit and Howard Gaynor of Hartford, Connecticut.

Through the expansion, Abiomed has invested more than $40 million into Massachusetts for education, manufacturing and training, according to the company.

“With Massachusetts-based companies like Abiomed helping to lead the way, the Commonwealth continues to be a global leader in health care, innovation and technology,” Baker said in a news release. “I am pleased to continue to witness the growth of a company that has invested in Massachusetts for more than 35 years and we look forward to continuing to work together to create jobs and develop the state’s innovation economy.”

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.